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Abstract
Background: Dengue fever is an increasingly significant arthropod-borne viral disease, with at least 50 million cases per year
worldwide. As with other viral pathogens, dengue virus is dependent on its host to perform the bulk of functions necessary
for viral survival and replication. To be successful, dengue must manipulate host cell biological processes towards its own
ends, while avoiding elimination by the immune system. Protein-protein interactions between the virus and its host are one
avenue through which dengue can connect and exploit these host cellular pathways and processes.
Methodology/Principal Findings: We implemented a computational approach to predict interactions between Dengue
virus (DENV) and both of its hosts, Homo sapiens and the insect vector Aedes aegypti. Our approach is based on structural
similarity between DENV and host proteins and incorporates knowledge from the literature to further support a subset of
the predictions. We predict over 4,000 interactions between DENV and humans, as well as 176 interactions between DENV
and A. aegypti. Additional filtering based on shared Gene Ontology cellular component annotation reduced the number of
predictions to approximately 2,000 for humans and 18 for A. aegypti. Of 19 experimentally validated interactions between
DENV and humans extracted from the literature, this method was able to predict nearly half (9). Additional predictions
suggest specific interactions between virus and host proteins relevant to interferon signaling, transcriptional regulation,
stress, and the unfolded protein response.
Conclusions/Significance: Dengue virus manipulates cellular processes to its advantage through specific interactions with
the host’s protein interaction network. The interaction networks presented here provide a set of hypothesis for further
experimental investigation into the DENV life cycle as well as potential therapeutic targets.
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Introduction
With over 50 million cases per year, dengue virus (DENV) is a
significant and growing threat to world-wide human health. Wide-
spread among tropical and sub-tropical regions, this NIAID
Category A pathogen consists of four serotypes, DENV1 to
DENV4, and is a member of the family Flaviviridae [1]. DENV
causes a range of diseases in humans, from the mild Dengue Fever
(DF) to the more deadly Dengue Hemorrhagic Fever (DHF) and
Dengue Shock Syndrome (DSS). While both the average number
of cases reported to the WHO as well as the number of countries
reporting cases of DENV have increased dramatically in the past
five decades, relatively little is known about this important tropical
pathogen that still lacks a vaccine, specific drug treatment, and
relevant animal model [2].
An arbovirus, DENV is carried and spread to humans by the
primary mosquito vector Aedes aegypti and to a lesser extent Aedes
albopictus. Thus, DENV displays the remarkable capability to
survive and replicate in two very different host organisms;
accomplished by a genome encoding a mere 10 proteins [3]. To
be successful, DENV must be able to manipulate each of its hosts
at a molecular level. This manipulation must be accomplished, in
part, through specific protein-protein interactions that allow the
virus to bend existing host cellular systems to the purpose of
furthering the viral lifecycle. However, understanding this host-
pathogen system is particularly difficult given the complexities of
host-virus dynamics as well as the lack of a useful animal model
system. In light of these challenges, computational approaches
provide an important tool in studies of host-pathogen systems. In
particular, computational approaches for predicting host-patho-
gen protein interactions provide opportunities for identifying
specific targets for further experimental work, understan-
ding system behavior, and determining plausible therapeutic
candidates.
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cerevisiae, prediction of protein interactions between species are
rare, and are especially so for host-pathogen interactions. Recent
computational work has considered interactions between P.
falciparum and human proteins based on interactions between
orthologous eukaryotic proteins or using statistics about protein
domains involved in within-species interactions [4,5]. For the
HIV-human system, Tastan et al. used a data mining approach to
predict host-virus interactions based on human protein features
and knowledge of existing protein interactions [6]. Also focused on
HIV, Evans and colleagues used short sequence motifs conserved
in both HIV and humans as the basis for interaction predictions
[7].
Protein structure information can also be used as a basis for
protein interaction prediction [8–10]. Here, given a set of proteins
with defined structures and known interactions, interactions can
be mapped to another set of proteins possessing similar structures.
This has been applied to HIV-human interactions as well as to
non-viral pathogens for a number of tropical diseases [11,12].
Unfortunately, despite their potential value, such computational
structure approaches have not been widely applied to the problem
of predicting host-pathogen interactions. In particular, we are not
aware of any studies focused on computational large-scale
prediction of protein-protein interactions between DENV and
humans and know of only one recent study related to Aedes [13].
Here, we establish a network of predicted interactions between
DENV proteins and proteins from its human and insect hosts.
These predictions are based on protein structural similarity, where
we first determine structural similarities between pathogen and
host proteins using an established method for comparing 3D
structures. We refer to host proteins having a region of high
structural similarity to a DENV protein as ‘‘DENV-similar.’’ Next,
we identify known intra-species interactions for these DENV-
similar proteins, and refer to the one or more host proteins that
they interact with as ‘‘targets.’’ We then assume that the similar
structural features seen between DENV proteins and their host
DENV-similar counterparts allow the DENV protein to partici-
pate in the same interactions as DENV-similar proteins; joining
the host protein network at these points (Figure 1). We prioritize
the interaction map using data from recent RNAi screens, to
create a smaller network of interactions having the greatest
potential to be correct. These predictions include numerous novel
interactions with potential functional relevance and we highlight
predictions relevant to stress, the Unfolded Protein Response
(UPR) as well as interferon pathways. This computational network
approach provides an additional tool for the investigation of
poorly-characterized host-pathogen systems such as DENV, as
well as helping to identify potential targets in both hosts that may




Structures of DENV2 proteins were taken from the PDB
(downloaded on Dec. 9, 2009), and any DENV2 protein without a
known structure was modeled using I-TASSER [14,15]. The
protein sequences used to create I-TASSER models were Entrez
Protein 159024813, 159024814, 159024817, and 159024819.
Default settings were used, with no restraints nor selection/
exclusion of any templates. Each of the structures for DENV
proteins was run on the DaliLite v. 3 webserver [16,17]. HPRD
Release 7 was used to obtain known human protein-protein
interactions, while known D. melanogaster interactions were taken
from DroID v5.0 and IntAct [18–20]. The A. aegypti orthologs of
D. melanogaster proteins were determined using the Inparanoid
ortholog annotation for the D. melanogaster genes in FlyBase v.
FB2009 10 [21,22]. The literature sources and various databases
used each have their own system of identifiers. PDB codes
obtained from Dali were mapped to their corresponding
taxonomy and Uniprot accessions using data from the SIFTS
initiative, which aims to ease the integration of data from multiple
databases (http://www.ebi.ac.uk/msd/sifts/) [14,23]. Other iden-
tifier mappings were carried out using DAVID Gene ID
Conversion or Uniprot ID mapping (DAVID 6.7, Uniprot Release
15.14) [24–26]. Network diagrams were created in Cytoscape
[27]. Images of protein structures were created in MacPyMol [28].
Determination of Structural Similarity between DENV and
Host Proteins
We investigated protein mimicry using structural similarities
from Dali. Dali compares the 3D structural coordinates of two
PDB entries by alignment of alpha carbon distance matrices,
allowing for differences in domain order, and produces a structural
similarity score [14,16,17]. For this study, we ran each of the
DENV2 protein structures, both known and predicted, through
the DaliLite webserver, which searched against the entire PDB for
structurally similar proteins, with a z score above 2.0. Default
settings of a score cutoff of 40 bits and sequence overlap cutoff of
50% were used. We then took from these results only those
structures that were from the species H. sapiens and D. melanogaster.
We refer to these human proteins as hDENV-similar proteins and
the fly proteins as dDENV-similar proteins.
Interaction Prediction
To predict which human proteins may interact with DENV2
proteins, we sought those target human proteins that interact with
the hDENV-similar proteins during cellular processes. To this end,
we determined known interactions between hDENV-similar
proteins and target human proteins, using data from the Human
Protein Reference Database (HPRD) database, which contains
literature curated interactions between pairs of human proteins
[18]. For each hDENV-similar protein, we predicted that the
target proteins which are known to interact with the hDENV-
similar protein might also interact with that DENV protein.
Author Summary
Dengue virus (DENV) represents a major disease burden in
tropical and subtropical regions of the world, and has
shown an increase in the number of cases in recent years.
DENV is transmitted to humans through the bite of an
infected mosquito, typically Aedes aegypti, after which it
begins the infection and replication lifecycle within human
cells. To perform the molecular functions required for
invasion, replication, and spread of the virus, proteins
encoded by DENV must interact with and alter the
behavior of protein networks in both of these hosts. In
this work, we used a computational method based on
protein structures to predict interactions between DENV
and its human and insect hosts. We predict numerous
interactions, with many involved in known cell death,
stress, and immune system pathways. Further investiga-
tion of these predicted protein-protein interactions should
provide targets to combat the clinical manifestations of
this disease in humans as well as points of intervention
focused within the mosquito vector.
Dengue-Host Protein Interaction Networks
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DENV2 proteins and A. aegypti proteins, but with the added step of
finding orthologs between A. aegypti and D. melanogaster proteins.
Known interactions between the dDENV-similar proteins and
other D. melanogaster proteins were taken from DroID, using a
cutoff confidence value of 0.4, and IntAct [19,20]. Then, orthologs
of the D. melanogaster proteins were found for A. aegypti using
FlyBase [22]. We then made the prediction that the A. aegypti
target protein interacts with the DENV protein.
GO Term Enrichment
The Gene Ontology (GO) provides a system of terms to
consistently describe and annotate gene products [29]. GO term
enrichment was performed using the DAVID Functional Annotation
Chart tool [24,25]. The GO is organized as a tree structure, with
terms becoming more specific as distance from the root increases.
Therefore, to avoid very general and uninformative GO terms, we
used only GO level 4 terms. The p-values were corrected for multiple
testing using the Bonferroni procedure and {log10 transformed.
Validation of Predictions
Since there may be multiple PDB structures present in Dali to
represent the same protein, there was some redundancy in the
interaction predictions. In some cases, multiple PDB structures for
the same DENV protein were found to be similar to multiple PDB
structures for an DENV-similar protein, leading to the same
interaction predictions. Therefore, the predictions were counted as
unique pairs of human Uniprot accessions and DENV protein
names. In addition, for ease of viewing the predicted interactome,
each node representing an DENV protein is labeled with the
protein name while each human protein is represented by Entrez
GeneID.
Support for the predicted interactions was obtained from
literature. As few interactions between DENV and humans are
known, we looked within the literature to see if any of them were
predicted by our method [30–33]. In addition, recent studies using
siRNA screens have found proteins that may play some role, either
facilitatory or inhibitory in DENV infection, in both humans and
D. melanogaster [34,35]. A. aegypti orthologs of these host factors were
recently curated by Guo et al. [26]. We checked for the presence
of these human host factors or mosquito orthologs among our
predictions. Although it is not known if these proteins act through
direct protein-protein interactions with DENV or indirect
mechanisms, their involvement in DENV infection provides
functional support for a possible interaction and gives them higher
priority for further testing.
Figure 1. Diagram of approach. (A) Predictions for the human host. Interactions between DENV proteins and human targets is predicted on the
basis of structural similarity between the DENV protein and an hDENV-similar protein, and the hDENV-similar protein’s known interaction with the
human target. (B) Predictions for the insect host are made in a similar manner as (A), except for the additional step of finding orthologs of the D.
melanogaster target proteins in the real host of interest, A. aegypti.
doi:10.1371/journal.pntd.0000954.g001
Dengue-Host Protein Interaction Networks
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GO annotations for the human and A. aegypti target proteins
were obtained through DAVID 6.7 [24,25]. However, since
DAVID assigns all DENV proteins the same GO terms, GO
annotation for the DENV proteins was obtained using the
GOanna webserver, provided through AgBase v. 2.00 [36]. This
tool assigns GO terms to the input sequences by transitively
assigning the GO terms of similar, already annotated sequences
identified by BLAST. The most significant BLAST hits for the
DENV protein sequences were DENV polyprotein sequences.
However, there were multiple polyprotein sequences, each with
their own annotations. The input sequences matched more
significantly to some polyproteins than to others, and were
therefore assigned different GO terms based on sequence
similarity. The predicted interactions were filtered so that only
those predictions for which the DENV protein and host protein
shared at least one GO cellular component term were retained.
Predictions Using Mosquito Interactome
Guo et al. recently generated a first draft of the mosquito
interactome [13]. Because their interactome was based on the
three model organisms A. aegypti, C. elegans, and S. cerevisiae,w e
found proteins from all three of these species that show structural
similarity with DENV2 using the Dali server [14,16]. The A. aegypti
orthologs of C. elegans and S. cerevisiae proteins were determined
using InParanoid, and the D. melanogaster orthologs were taken
from the InParanoid ortholog annotation for the D. melanogaster
genes in FlyBase v. FB2009 10 [21,22]. Then, the interactions with
these orthologs taken from the mosquito interactome were used to
map predicted interactions between DENV2 and mosquito target
proteins. For the GO term enrichment, we used only GO terms
from DAVID’s GO fat set, to eliminate non-specific terms with
many children.
Determining Orthologous Targets
The genome-wide set of orthologs between human and A. aegypti
was downloaded from InParanoid 7.0 Refworks:161. Since
InParanoid lists human proteins by their Ensembl Protein IDs,
mappings to Uniprot accessions were downloaded from Ensembl
57 using BioMart Refworks:192. Orthologous human and A.
aegypti targets that were predicted to interact with the same
DENV2 protein were identified.
Results and Discussion
Identification of Dengue-Similar Host Proteins
To develop a network of interactions between DENV and its
hosts, H. sapiens and A. aegypti, we employed a method we
developed previously in the prediction of protein interactions
between HIV and human [12] (see Methods for further details).
First, we obtained 3D structures for the DENV proteins, from two
sources. Experimentally determined structures were taken from
the PDB and consist of 31 PDB entries representing the DENV2
proteins E, pr peptide, prM, C, NS2B, NS3, and NS5 [37]. Since
there are no experimentally determined structures for NS1, NS2A,
NS4A, and NS4B, we used the I-TASSER server to predict the
structure of these proteins [15]. In this way, we investigated
possible interactions for every DENV protein.
To determine structurally similar host proteins, we used
DaliLite to compare DENV structures against every other
structure in the PDB [16,17,37]. We considered only significant
structural matches with proteins from DENV’s hosts. We found
300 human proteins with similarity to a DENV protein (hDENV-
similar). However, we found no similarities between DENV
proteins and A. aegypti proteins. This is not surprising, given there
are currently only 17 structures from A. aegypti in the PDB.
Therefore, we looked for similarities between DENV proteins and
the fly, Drosophila melanogaster, and found 15 proteins with structural
similarity to DENV, which were then used as dDENV-similar
proteins in downstream analyses.
Known DENV-Host Interactions
A particular challenge in host-pathogen studies is the general
lack of interaction data. HIV is perhaps the most well-
characterized virus in this regard, with over 800 direct interactions
documented in NCBI’s HIV-Human protein interaction database
(over 2500 interactions if indirect interactions are included) [38].
In contrast, a recent compilation of host-pathogen interactions
from public databases describes a total of 3 DENV-human
interactions [39].
Through a more comprehensive search of the literature, we
have found 20 documented interactions between DENV and
human proteins (Table 1). Almost half of the documented protein
interactions involve E protein and a receptor on the cell surface.
Two of these, CD14 and HSPA5, have been shown to function as
DENV receptors, although their binary interaction with E protein
was not explicitly demonstrated; it may be that some other protein
in complex with these receptors is the direct interaction partner of
E protein [40,41]. Furthermore, there is evidence that DENV
receptor usage may be virus strain and cell type dependent [42].
Indeed, RPSA has been shown to be a DENV receptor, suggesting
an interaction with E, but only for DENV1 [43]. Because our
predictions were focused on DENV2, this interaction was not
considered for our predictions, but was included in Table 1.
Interactions not shown to be specific for a different serotype were
included in our list of true positive interactions. Therefore, a total
of 19 protein interactions were considered as known host-pathogen
interactions between DENV2 and human.
We are currently unaware of any well-characterized protein-
protein interactions between DENV and A. aegypti. However, in
the C6/36 cell line from Aedes albopictus, tubulin is believed to
interact with DENV2 E protein [44]. In addition, one protein,
likely to be HSP90, has been put forward as a putative receptor for
DENV2 in A. aegypti, having been shown to bind to the E protein
[45]. However, its identity has not been conclusively demonstrat-
ed. In addition, mosquito La auto-antigen is known to interact
with the 39 end of DENV RNA and may play some role in RNA
synthesis [46]. Human La auto-antigen (SSB) is also known to
interact with the ends of the viral RNA, as well as NS3 and NS5
[47]. If the functions of the mosquito and human La proteins in
DENV infection are similarly conserved, mosquito La may
interact with NS3 and NS5 as well, although this has not been
shown. It is likely that some of the protein interactions which
enable DENV to manipulate the cellular pathways of two hosts are
conserved between the species.
Prediction of Protein Interactions
After determining which host proteins are structurally similar to
DENV proteins, we inquired into the known protein-protein
interactions that each DENV-similar protein participates in. For
the hDENV-similar set, we obtained known human protein
interactions from the Human Protein Reference Database
(HPRD), which consists of over 37,000 interactions found in the
literature [18]. We predicted that the DENV proteins could
interact with the partners of their corresponding hDENV-similar
proteins, under the hypothesis that proteins with highly-similar
structures are likely to be involved in similar protein interactions
(Figure 1A). We predicted 4,273 potential host-pathogen interac-
Dengue-Host Protein Interaction Networks
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19 known protein-protein interactions between DENV and
human, 9 are present among our predictions [30–33,40,41,47–
55]. This method may not predict all interactions, for example
those mediated by sequence motifs rather than structural features.
A table of all DENV-human protein interaction predictions is
provided in Table S1.
For the dDENV-similar proteins, we used the interactions
curated in IntAct for D. melanogaster, as well as potential D.
melanogaster interactions suggested by the yeast-2-hybrid data sets in
DroID [19,20]. However, rather than making direct predictions
using these interactions, as we did for human proteins, we
determined orthologs of the D. melanogaster proteins in A. aegypti,
since this is the true host of DENV. We then predict that the A.
aegypti ortholog of a D. melanogaster protein that interacts with a
dDENV-similar protein may also interact with the corresponding
DENV protein (Figure 1B). As a result of this procedure, we
predict that 158 A. aegypti proteins participate in 176 interactions
with DENV proteins (Table 2). We note that this method did not
predict interactions between E and mosquito tubulin, HSP90, or
La, which have been suggested as possible interactions [45–47].
However, 12 of the predictions involved orthologs of proteins
involved in DENV2 infection in humans or fly. A table of all
DENV-Aedes protein interaction predictions is provided in Table
S2.
Assessment of Predictions
GO term enrichment. Due to the sparseness of known
interactions to which we can compare and evaluate our
predictions, we examined the functional roles of host proteins
for patterns relevant to DENV infection. To this end, we
determined the amount of GO term enrichment among the
DENV-similar and target proteins for each host. We find that
many of the most significantly enriched terms among these sets of
proteins are for processes or functions known to be important for
DENV infection (Figure 2). Our results are also consistent with a
study of altered protein expression during DENV infection in
which several of the proteins identified have functions related to
the GO terms RNA processing, transcription, or regulation of
stress response, which were enriched in our predictions [56].
For human target proteins (dark blue bars in Figure 2A),
processes involving signaling, cell death and apoptosis, and
positive or negative regulation terms are much more frequent
than would be expected if chosen at random. These processes are
in agreement with processes and pathways that are known to be
altered during the course of infection. Human proteins with
structural similarities to DENV (red bars) are enriched for terms
describing blood coagulation and hemostasis, indicating that
DENV proteins appear to have structural similarities that mimic
human proteins involved in the pathways controlling the cessation
of bleeding. One of the defining symptoms of DHF is hemorrhage,
the pathogenesis of which has been shown to include abnormalities
in levels of cytokines, complement components, and coagulation
factors [57,58]. DENV proteins show structural similarity with
proteins from all three of these categories. In fact, DENV mimicry
of clotting factors has already been observed: antibodies against
the DENV2 protein NS1 have been shown to cross-react with
clotting factors and integrins on thrombocytes and endothelial cells
[59]. Kinase, cytokine, phosphotransferase, and peptidase func-
tional roles are also enriched in hDENV-similar and human target
proteins.
The most enriched biological processes for DENV-A. aegypti
within our interaction predictions appear to revolve around RNA
processing and transcription-related processes. This is observed in
enriched functions which include ‘‘nucleotidyltransferase activity’’
and ‘‘sequence-specific DNA binding’’ GO terms (Figure 2B).
Gene expression analyses within A. aegypti in response to DENV
infection have shown changes in several hundred genes across a
range of functions, with immune and transcriptional processes
being highly represented [60]. We note that one protein with
mRNA processing activity, AAEL013723-PA or polypyrimidine
Table 1. Known interactions between H. sapiens and DENV.
Human DENV Serotype System Reference
UBE2I E 2 in vitro
{ [32]
HSP90AA1 E 2 U937, SK-SY5Y,
monocyte
[33]
HSPA4 E 2 U937, SK-SY5Y,
monocyte
[33]
HSPA5 E 2 HepG2,Vero [41,55]
CANX E 2 Vero [55]
CALR E 2 Vero [55]








DAXX C 2 HepG2 [49]
HNRNPK C 2 293T
{ [30]
HNRNPC NS1 2 HEK 293T [50]
CLU NS1 2 plasma, 293T, Vero [51]
STAT3 NS1 2 BHK [52]
NRBP1 NS3 2 BHK
{ [31]
SSB NS3 4 U937 [47]
SSB NS5 4 U937 [47]
TJP1 NS5 2 epithelial cells [54]
STAT2 NS5 2 293T [80]
PTBP1 NS4A 2 Huh-7 [53]
Experimentally determined nteractions are listed, with the serotype and system
that they were demonstrated in.
{Interaction suggested in one or more (additional) cell lines by functional assay.
{Interaction suggested for other serotypes by functional assay.
*Interaction shown to be specific for this serotype.
doi:10.1371/journal.pntd.0000954.t001
Table 2. Interaction predictions summary.
Human Human CC Insect Insect CC
Dengue-
similar
300 254 15 6
Targets 2,321 1,099 158 12
Known
Predictions
9 7 NA NA
Host Factor
Predictions
48 20 12 1
Total
Predictions
4,273 2,073 176 17
Counts are given for the predictions made between DENV and both the human
and A. aegypti hosts, both before and after CC filtering. Known Predictions for A.
aegypti is listed as NA because we are aware of no known protein-protein
interactions between DENV and A. aegypti.
doi:10.1371/journal.pntd.0000954.t002
Dengue-Host Protein Interaction Networks
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known to interact with NS4A [53]. However, we predict
AAEL013723-PA interacts with NS2A in A. aegypti and make no
predictions about PTBP1 interacting with DENV in humans
(Table S2). In addition, there are several lines of evidence
suggesting that A. aegypti may use the RNAi pathway as a defense
against infection by DENV and variations in the RNAi pathway in
both the host and viral strains may contribute to differences in the
efficiency of infection [61].
Literature filtering. Our prediction of host-DENV
interactions using protein structural similarity allows us to
generate a list of candidate interactions with potentially significant
functional relevance, forming a possible basis for further
experimental and computational studies of this system. Given the
large number of predictions as well as the sparsity of known
interaction information, we wished to incorporate additional data to
help refine these predictions into a ‘‘increased-confidence’’ set of
interactions. To do this, we incorporated functional information
from recentliterature. Specifically, two siRNAscreenshaverecently
examined the roles of host proteins in DENV infection [34,35].
Sessions et al. performed a genome-wide siRNA screen for D.
melanogaster proteins whose depletion affected the ability of DENV2
to infect the host cells. For those insect host factors with human
homologues, they verified 55 as human host factors, also using
siRNA [34]. In addition, Krishnan et al. identified 123 human host
factors for DENV in a study primarily searching for West Nile Virus
host factors, but also testing these proteins in DENV infection [35].
In total, these two studies implicated 173 human proteins and 116
D.melanogaster proteinsasplayingaroleinDENV infection.Wenote
that similar studies in HIV together have revealed nearly 1000 such
human host factors, and thus it is unlikely that these studies have
identified all such factors in DENV hosts.
While host factors may act through mechanisms other than
direct protein interactions, their functional involvement in DENV
infection makes them more likely to participate in host-pathogen
protein interactions. Comparing the identified host factors against
our predictions, we found that 48 of the human target proteins
were also identified as host factors in the siRNA screens, as well as
3 of the D. melanogaster targets (Figure 3 and Table 2). Many host
proteins are predicted to interact with both NS2A and NS4B. This
is due to apparent structural similarities between these two DENV
proteins; several of the hDENV-similar proteins for NS2A and
NS4B are the same. In particular, many predictions for both
proteins are based on regions of structural similarity to members of
the 14-3-3 family, protein phosphatase 2 regulatory subunits, and
beta-catenin. These hDENV-similar proteins are key signaling
proteins, with many known interactions. 14-3-3 proteins have been
found to interact with over 200 polypeptides involved in highly
diverse cellular functions [62] and PP2 is a serine-threonine
phosphatase and tumor suppressor [63]. Beta-catenin is a well
known member of the Wnt signaling pathway. The other two
DENV proteins that have no known structure, and hence have
predictions based on modeled structures, do not show structural
similarity to 14-3-3 or protein phosphatase proteins. The
combination of a predicted interaction along with siRNA
functional relevance suggests that these host-DENV relationships
would form the basis of a high-priority candidate list for future
investigation.
Subcellular co-localization. As an additional method of
identifying the most well-supported predictions, we also filtered
predictions based on subcellular co-localization. The obvious
assumption here is that for two proteins to directly interact, they
must be physically present together within the same cellular
compartment. Therefore, we used shared GO cellular component
Figure 2. GO term enrichment of host proteins. (A) Enriched GO biological process terms. (B) Enriched GO molecular function terms. Blue bars
represent terms enriched among human target proteins, red is terms enriched among hDENV-similar proteins, light blue is terms for A. aegypti
targets, and pink is for terms from dDENV-similar proteins. When more than ten terms were enriched for a set of proteins, only the ten most
significant terms are shown. Bonferroni corrected p-values were transformed by {log10. The following abbreviations are used: ‘‘reg’’ is ‘‘regulation
of,’’ ‘‘pos’’ is ‘‘positive,’’ ‘‘neg’’ is ‘‘negative,’’ ‘‘proc’’ is ‘‘process,’’ ‘‘peptidase activity L-aa peptides’’ is ‘‘peptidase activity acting on L-amino acid
peptides,’’ and ‘‘phosphotrans alcohol group’’ is ‘‘phosphotransferase activity alcohol group as acceptor.’’ Brackets delineate the two host species.
doi:10.1371/journal.pntd.0000954.g002
Dengue-Host Protein Interaction Networks
www.plosntds.org 6 February 2011 | Volume 5 | Issue 2 | e954(CC) annotation to filter our predicted interactions. While this
filtering should highlight a smaller set of proteins having additional
evidence of interaction, we note that CC annotation is very noisy,
with the localization of proteins within a cell being often poorly
characterized for even well-studied model organisms, let alone
species such as DENV or A. aegypti.
As GO annotations taken from DAVID for DENV are linked to
entries for the DENV polyprotein rather than the individual
proteins, all DENV proteins receive the same annotations. To
ameliorate this problem and to include proteins with modeled
structures, we assigned GO terms to the sequence corresponding
to each DENV protein structure using a different tool, GOanna,
which finds possible annotations based on the annotations of
highly significant BLAST hits [36]. By assigning GO terms in this
way, we were able to find CC terms for all of the DENV proteins.
We used this information to create a smaller list of predicted
interactions, containing only those predictions where the DENV
protein and the host target share at least one GO CC term. After
CC filtering, there were 2,073 predicted interactions between
DENV and 1,099 human proteins. Seven of the 19 known DENV-
human interactions remained after filtering (reduced from 9 of 19),
as well as 20 interactions involving host factors (Table 2). The two
known interactions that were removed during CC filtering were
UBE2I and HSP90AA1 interacting with E. The CC filter reduced
both the total number of predictions and the ones containing host
factors by about half, leaving many fewer predictions with only a
small decrease in predictions already having known functional
support. For the predicted interactions in A. aegypti, the reduction
in predictions was more pronounced, with only 17 predictions and
12 targets passing the CC filter (Figure 4). One of these predictions
involves a host factor, as compared to 12 of the 176 predictions
before filtering. While GO compartment information is incom-
plete, CC filtering does provide a smaller list of predictions, and in
the case of human-DENV interactions, with only a slight decrease
in the ability to predict known interactions. Full tables of
interactions incorporating CC filtering are provided in Tables
S3 (human) and S4 (A. aegypti).
Prediction accuracy. It is difficult to judge the accuracy of
predictions for protein interactions in host-pathogen systems,
especially for those pathogens such as DENV that have received
less attention than their worldwide burden deserves. However, our
results include essentially half (47%) of the known interactions
between DENV and human proteins, as well as a significant
number of proteins from both human and fly that have been
Figure 3. Predicted interactions with literature support. Predicted interactions between DENV and its hosts. Only predictions that were
already known and those involving host factors are shown. Solid lines represent interactions for which the host protein was found by an siRNA screen
to be involved in DENV infection, while dashed lines indicate that it is not a known host factor. Red lines represent interactions already known from
the literature.
doi:10.1371/journal.pntd.0000954.g003
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Protein interaction prediction is a difficult problem, with even a
slight improvement over random guessing considered a success. In
a recent attempt to predict protein interactions in yeast, the
organism with the most complete known interactome, the best
method tested was able to predict 60% of the known interactions,
outperforming several previous methods having accuracies as low
as 38% [64]. Another study evaluating the performance of three
prediction methods based on protein domains showed that all
three performed only slightly better random guessing on
benchmark datasets [65]. A large set of known interactions that
could serve as a gold standard for humans and DENV is lacking,
but based on the small number of DENV2-human interactions
that are known, we estimate that the accuracy of our method is
comparable to that of other methods applied to better
characterized systems such as yeast. Certainly there are many
protein-protein interactions and host factors that remain to be
discovered. As previously mentioned, HIV, another virus which
encodes only a handful of proteins, is known to participate in over
800 direct interactions with human proteins, with over 2500
interactions if ones that may be indirect are included [38]. It seems
reasonable to assume that DENV2 also participates in a large
number of host-pathogen interactions, most of which are currently
unknown.
We have also applied this methodology to the prediction of
protein interactions between HIV and human, a host-pathogen
system for which much is known, although the same problems still
exist to some extent [12]. In that work, we found that at the level
of proteins, a minimum of 6% of predictions are correct. As there
are often multiple protein/structure entries defined for each gene,
when we consolidate proteins to single genes, at least 10% of our
predictions were estimated to be correct when comparing
predictions involving HIV host factors that passed CC filtering
to known HIV-human protein interactions. This represented a
significant improvement over random predictions (1% of random
predictions were correct). For the DENV-host systems described in
this work, we similarly estimate that, at a minimum, approximately
10% of predictions provided here are correct. It is encouraging
that, comparable to yeast studies, we were able to find
approximately 50% of the currently known interactions between
DENV and human.
Comparison to another dataset. As discussed earlier, the
major challenge in predicting protein interactions for pathogens is
the lack of interaction data. A further complication is that, in
addition to the lack of known host-pathogen interactions for
DENV2, little is known about protein interactions within the
mosquito vector itself. Very recently, a draft of the A. aegypti
interactome was predicted by assuming that the mosquito
orthologs of interacting proteins in C. elegans, D. melanogaster, and
S. cerevisiae would also interact [13]. Since so little is known about
the insect vector, we felt it would be valuable to compare our
results to another set of predictions made using our general
method, but based on this newly-predicted mosquito interactome.
To do this, we found structural similarity between DENV2
proteins and fly, worm, or yeast proteins, mapped these similar
proteins to their orthologs in mosquito, then used the mosquito
interactome to predict host-pathogen interactions. In comparison,
we previously used only fly proteins that were similar to DENV2
proteins, linked them to interacting proteins from experimentally
determined fly interactions, then found the mosquito orthologs to
map our predictions.
When we expanded our search for DENV-similar proteins to
include all three model organisms, we found 45 proteins (vs. 15 in
our original set) that showed structural similarities to DENV2
proteins. We then mapped these proteins to orthologs in A. aegypti.
Any A. aegypti proteins predicted to interact with these orthologs,
according to the recently published mosquito interactome, were
predicted to interact with DENV2. As a result, we found 263
mosquito targets participating in 351 interactions with DENV2
proteins (Table S6). This can be compared to the 158 targets and
176 interaction predictions generated by considering Drosophila
interactions alone (Table 2). The larger number of interactions
predicted is a result of including more protein structures from
additional species. Overall, the predictions based on the new data
showed a similar GO term enrichment as compared to our
original results (Figure S1).
It is difficult to directly assess prediction quality due to the
absence of known interactions between DENV2 and mosquito.
However, we note that despite the larger number of predictions,
fewer involved proteins that were suggested to be host factors (10
compared to 12 in the original predictions). This suggests that the
larger number of predictions may represent an increase in the
number of false positive predictions. Indeed, some of the within
mosquito interactions used to produce this larger set of interactions
may also be false positives, as the interactions of [13] are predicted
from interactions in other species. The evolutionary distances
between A. aegypti, worm and yeast may be too great to provide
accurate predictions of protein interactions using orthologs. A
network of the fourteen predictions made using both datasets is
given in Figure S2. In addition, Guo et al. predicted 22
Figure 4. Predicted interactions in A.aegypti after CC filtering. Predicted interactions between DENV and A.aegypti where the DENV protein
and its target share at least one GO CC term. Solid lines represent interactions for which the A.aegypti protein is a host factor.
doi:10.1371/journal.pntd.0000954.g004
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proteins from any host species shown to interact with proteins
from any flavivirus [13]. Only 3 of the A. aegypti proteins they
predict to interact with DENV2 (AAEL012515, AAEL014959,
and AAEL013600) are present among the predictions made with
our method using Drosophila experimental interactions alone. In
addition, we predict them to interact with different DENV2
proteins than what is predicted in [13].
Stress and Apoptosis in DENV Pathogenesis
We note several links between DENV pathogenesis, stress
responses, and apoptosis among our predictions and in the
literature. The GO term ‘‘regulation of stress response’’ is enriched
among hDENV-similar proteins, as well as several terms related to
apoptosis among the human target proteins. Several potential
DENV receptors are involved in stress responses, such as HSP90,
HSPA4, and HSPA5 [33,41]. In particular, flaviviruses assemble
within and bud from the ER, and are known to induce the
Unfolded Protein Response (UPR), which reacts to stressors of ER
function. As the UPR is necessary for cell survival during infection,
but also has a negative impact on viral replication, modulation of
this response by DENV may be advantageous. The UPR can
induce either survival or apoptosis signals depending on the
strength and duration of the ER stressor [66]. Three major
branches, running through PERK, ATF6 and IRE1, regulate the
UPR and ER homeostasis, and all three have been shown to be
induced by DENV infection (Figure 5) [67].
Activation of PKR-like ER kinase (PERK), leads to phosphor-
ylation of the eukaryotic initiation factor 2a (eIF2a). This
phosphorylation inhibits the formation of translation initiation
complexes, leading to translation inhibition and a reduction in the
number of unfolded proteins within the ER [66]. Production of
ATF4 is also enhanced as a result of eIF2a phosphorylation,
eventually leading to GADD34 production. GADD34 acts within
a negative feedback loop, recruiting protein phosphatase 1, leading
to dephosphorylation eIF2a and the restoration of normal
translation efficiency. Persistent ER stress leads to CHOP
expression and promotion of apoptosis. It has been suggested that
DENV may be able to compensate the UPR response by inducing
dephosphorylation of eIF2a to restore translation [67]. We predict
interactions between NS4B and GADD34 (PPP1R15A) (Figure 5).
A listing of all predictions, with or without filtering, are provided in
Tables S1, S2, S3, S4, S5.
ATF6 is a bZIP family transcription factor that transits from the
ER to the Golgi in response to ER stress. It undergoes processing
in the Golgi and transits to the nucleus, leading to upregulation of
multiple apoptosis-relevant genes and eventual apoptosis. While
we do not predict any direct interactions with ATF6, we do predict
interactions between NS2A, NS4B, and C with associated
pathway member NFYA, which forms a complex with ATF6 in
response to ER stress [68] (Figure 5).
In the third branch of the UPR, the ER transmembrane protein
IRE1, containing both kinase and RNase activities, becomes
autophosphorylated and activated in response to ER stress, leading
to XBP-1 splicing and translation of UPR relevant genes. Both
DENV2 and Japanese Encephalitis Virus infection have been
shown to activate XBP1 and its downstream genes in N18 mouse
neuroblastoma cells, reducing the cytopathic effect of the virus
Figure 5. DENV and ER Stress. Potential interactions between DENV proteins and key components of the Unfolded Protein Response (UPR) and
ER stress. See text for additional details.
doi:10.1371/journal.pntd.0000954.g005
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shown to lead to greater cytotoxicity in response to infection [69].
Persistent stress leads to apoptosis through an IRE-JNK-BCL2
pathway. Our predictions suggest potential interactions between E
and BCL2. In addition, other BCL family members are also
predicted to interact with DENV proteins including BCL2ll (BIM;
a facilitator of apoptosis) with NS4B, BCL2L1 (BCLX; both pro-
and anti-apoptotic splice variants) with E and NS3, and BCL2L10
(Boo; supression of apoptosis induced by BAX but not BAK) with
NS3 (Figure 5).
A recent study investigating protein interactions between
DENV envelope protein and host proteins described direct
interactions between E and BiP (HSPA5), Calnexin (CANX) and
Calreticulin (CALR) [55]. All three major ER stress transducers
interact with BiP, which serves as a negative UPR regulator, and
along with other ER chaperones, facilitates proper folding of
proteins. Similarly, Calnexin and calreticulin are chaperones that
bind to glycosylated proteins. Our methodology predicts each of
these interactions with the E protein. In addition, we also predict
that CALR is likely to interact with NS1 as well as NS3. Overall,
these results suggests multiple sites within the host network at
which DENV proteins can potentially manipulate the Unfolded
Protein Response.
In addition, several studies have implicated NS3 in DENV-
induced apoptosis. The ability of DENV1 to cause apoptosis in
HepG2 cells differs across strains. The mouse neurovirulent strain
FGA/NA d1d differs from its parental strain, FGA/89 by 4
mutations, one of which leads to a non-conservative substitution in
NS3. FGA/NA d1d was shown to have a reduced capacity to
induce apoptosis, although whether this was mediated by the
mutation in NS3 or by one of the other mutations, which were all
in the E protein, is unclear [70]. However, Vero cells expressing
DENV2 NS3 undergo apoptosis by a mechanism that is
dependent on NS3 protease activity and enhanced by the presence
of NS2B [71]. In addition, West Nile Virus NS3 is sufficient to
induce caspase-8-depedent apoptosis, and is suggested to directly
interact with, cleave, and activate caspase-8 in NIH 3T3 cells [72].
We predicted a number of interactions between NS3 and
members of apoptotic pathways. A few examples of the structural
similarities that led to these predictions are shown in Figure 6. NS3
was predicted to interact with p53 based on structural similarities
with RAD51, TK1, and DDX5. Similarities with RAD51 also led
to predicted interactions with ABL1, BRCA1/2, CASP3, and
CASP7. Furthermore, NS3 has regions of similarity to APAF1,
and is therefore predicted to interact with BCL2L1, BCL2L10,
Fas, and the caspases -3, -4, -8, and -9. These results suggest that
NS3 may play a role in DENV pathogenesis by influencing
apoptosis in host cells, mediated by specific interactions between
NS3 and host proteins.
DENV and the Interferon Response
Humans and A. aegypti are known to use conserved defenses
against DENV infection, involving several signaling pathways of
the innate immune system, which is consistent with our finding of
enriched GO terms related to the immune system among the
target proteins of both humans and A. aegypti. In particular, the
JAK-STAT signaling pathway has been shown to modulate
susceptibility to DENV infection, in both mosquitos and humans
[73,74]. In humans, the JAK-STAT pathway can be activated by
the interferons (IFN), IFN-a, IFN-b, and IFN-c, and mediates the
antiviral response (Figure 7A). When IFN-a or IFN-b bind their
receptor, IFNAR, the tyrosine kinases JAK1 and TYK2 are
activated. This results in the phosphorylation and activation of
STAT2 and STAT1, which then recruit IRF9 to form a
transcription factor complex that transcribes IRF-7 and then the
set of genes that are induced by IFN-a. The interferon response is
known to be induced upon DENV infection and high levels of
IFN-a are normally present in the sera of DENV patients [75].
Furthermore, pretreatment of cells with IFN has been shown to
block negative strand accumulation of DENV RNA, but this
inhibition was strongly attenuated if treatment occurred even 4
hours after initial infection [76].
In fact, while infection induces an interferon response, several
studies have shown that DENV interferes with the signaling
pathway downstream of IFN-a. In dendritic cells, DENV is known
to protect itself from the antiviral effects of IFN-a by reducing the
phosphorylation of TYK2 and preventing the activation of
STAT1 and STAT3, although the effects of IFN-c are not averted
[74]. In addition, IFN-a-, but not IFN-c-, dependent phosphor-
ylation of STAT1 and STAT2 was found to be inhibited in A529
and HepG2 cells by the NGC strain of DENV2, but not by the
strain TSV01, suggesting strain-dependent rather than serotype-
specific differences in response [77]. Such strain-dependent
differences also highlight the possibility of viral RNA sequence
variations that potentially lead to changes in interaction specificity
or the strength of interaction with host proteins.
A few specific proteins have been identified as modulators of the
IFN response. For instance, IFN-b signaling was prevented by the
viral proteins NS4B, and to a lesser degree by NS4A and NS2A
[78]. Inhibition of signaling by NS4B was thought to occur
through an observed reduction in the level of phosphorylated
STAT1. Expression of STAT2 was also observed to be repressed
Figure 6. Structural similarities between NS3 and human proteins involved in apoptosis. (A) Structural similarity between NS3 and RAD51
(1n0wA [86]). (B) Structural similarity between NS3 and TK1 (1w4rA [87]). (C) Structural similarity between NS3 and APAF1 (1z6tC [88]). (D) Structural
similarity between NS3 and DDX5 (3fe2A [89]). NS3 (2bhrA [90]) is shown in red.
doi:10.1371/journal.pntd.0000954.g006
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bind to STAT2, resulting in reduced IFN signaling [80]. In this
same study, when expressed as a proteolytically processed
precursor, NS5 was also found to target STAT2 for proteasome-
mediated degradation. However, while it is clear that DENV is
actively involved in modulating the host interferon response, there
likely remain many specific interactions by which DENV proteins
inhibit IFN signaling that are not known.
Our predictions suggest many potential interactions between
DENV and multiple human proteins involved in the JAK-STAT
pathway (Figure 7B). In particular, for NS4B, we have predicted
possible interactions with IFNAR2, IFNGR1, JAK1, JAK2,
TYK2, PTPN11, PTPN2, PTPN6, PKR (EIF2AK2), STAT1,
STAT2, and STAT3. Thus, NS4B may reduce the observed
phosphorylation of STAT1 through direct interactions with the
host STAT1 protein, through interactions that effect the activities
of proteins upstream of STAT1 (e.g. JAK1 or TYK2), or through
interactions with at least one PTP protein, which are negative
regulators of STAT activity. In addition, NS4B is predicted to
interact with PKR, a key component of the IFN response in
blocking virus replication. A close relative of DENV, hepatitis C
virus, has been shown to inhibit interferon signaling through
inhibition of PKR as well as by competing with eukaryotic
translation initiation factor 2a as a PKR substrate [81,82]. NS2A
is also predicted to interact with the same members of the this
signaling pathway as NS4B. However, NS4A is predicted to
interact with IFNAR1, IFNAR2, IFNB1, JAK2, TYK2, PTPN11,
and SOCS1. In summary, we have predicted specific host-
pathogen protein interactions that may enable DENV to escape
the antiviral response induced by IFN and which can be tested in
the future to determine the precise mechanism by which DENV
manipulates this host system.
Orthologous Human and A. aegypti Targets
To complete its lifecycle, DENV must survive in two very
different hosts and must perform many of the same processes in
each, such as transcription and translation. Since some proteins and
essential processes are conserved between mosquitos and humans, it
is possible that some of the proteins that are manipulated by DENV
inonehostareorthologous totheproteinsused inthe otherhost.To
identify potential interactions of this type, we compared our
interaction network predictions before CC filtering for human and
A. aegypti to find proteins which are orthologous between the two
hosts, as well as predicted to interact with the same DENV protein
in each. We found 47 pairs of orthologs that were predicted to
interact with the same DENV protein (Figure 8). Four of these
predicted interactions represent host factor targets for A. aegypti.W e
note that ourmethod dependson known interactions withinspecies,
and may miss some orthologous host-pathogen interactions if the
within species interactions are not known.
To examine the functional role of these conserved interactions,
we performed GO term enrichment for biological process and
molecular function. No molecular function terms were significant-
ly enriched (Bonferroni corrected p-value ,0.01). Most of the
biological processes represented by orthologous interactions in
both hosts were also found enriched in the predictions for a single
host. For example, at least 17 of the human proteins and their
orthologs in A. aegypti are involved in mRNA processing or
metabolism (ASCC3L1, DCP1B, DCP2, HNRPA1, HNRPD,
HNRPF, HNRPM, UPF3B, WDR77, MAGOH, NCBP2,
PABPN1, PAPOLA, PRMT5, SNRPA1, SF3B3, SMN1). Five
of the interactions known to occur between DENV and human
proteins involve the mRNA processing proteins HNRNPK,
HNRNPC, PTBP1, and SSB [30,47,50,53]. ‘‘RNA processing’’
and ‘‘RNA metabolic process’’ were highly enriched in the
mosquito predictions and in the orthologous predictions.
In addition, we found a number of enriched GO terms relating
to the regulation or formation of synapses among the predictions
conserved in both species. Previously, the term ‘‘brain develop-
ment’’ was enriched in the set of dDENV-similar proteins.
DENV2 virus particles have been found in vesicles near the
presynaptic membrane in spinal cords of SCID mice, and it was
suggested that fusion of these vesicles at the synapse might aid the
spread of DENV2 from neuron to neuron [83]. In Culex pipiens
quinquefasciatus mosquitos, West Nile Virus, another flavivirus, was
also found near synapses and in synaptic vesicles [84]. Further-
more, DENV3 is known to infect the nervous system of A. aegypti,
altering the mosquito’s feeding behavior by prolonging feeding
and possibly enhancing the spread of DENV3 by making it more
Figure 7. DENV influences IFN signalling. (A) Interferon signaling
pathway. IFNA and IFNG bind to their respective receptors and cause
the activation of Jak family tyrosine kinases. This activats of STAT
proteins, which form hetero- or homodimers and induce the expression
of IFN response genes. SOCS proteins negatively regulate JAK1 and PTP
proteins negatively regulate JAK1 and STAT1. NS4B can reduce the
phosphorylation of STAT1. (B) Predicted interactions between DENV
proteins and members of the IFN-induced JAK-STAT pathway.
doi:10.1371/journal.pntd.0000954.g007
Dengue-Host Protein Interaction Networks
www.plosntds.org 11 February 2011 | Volume 5 | Issue 2 | e954likely that feeding will be interrupted, and the mosquito will have
to feed on additional humans [85].
The processes enriched in the predicted interactions conserved
between the two hosts are consistent with the effects of DENV
infection in each host. In particular, many of the terms enriched
among the orthologous predictions are similar to terms enriched
for mosquito predictions. This is not necessarily surprising, given
that the mosquito prediction set is much smaller than the human
one, but indicates that orthologous predictions in humans were
made corresponding to many of the mosquito predictions.
However, we found terms involving cell morphogenesis enriched
among the orthologous predictions, but not within the predictions
specific to either host. Therefore, the mosquito-specific predic-
tions do not completely overlap with the human predictions, and
new processes key to DENV infection in both hosts can be
revealed.
Conclusion
We have created a map of potential protein-protein interactions
between the host-pathogen triad DENV2 and its hosts H. sapiens
and A. aegypti. The computational methodology employed to
generate this map assumes that proteins with comparable
structures will share interaction partners. Therefore, we predict
that DENV2 proteins may merge into the host protein
interactome at the points normally occupied by structurally
similar host proteins, creating an interface for the manipulation
of downstream host processes. From previous studies, a number of
human and fly proteins have been suggested to play some role in
DENV2 infection, although the nature of this role is unknown in
most cases. Using this methodology, we are able to make
predictions regarding which host proteins may impact viral
infection through interactions with specific DENV2 proteins. We
note that the structural-based methodology here provides a larger
picture of the interaction network, while more subtle changes at
the sequence level are likely to explain experimentally observed
differences in strain effects. Given the paucity of both structural
and interaction data for this system, we cannot determine fine
differences between strains, but this may be elucidated by further
study. The networks presented here may help to provide a set of
hypotheses for further investigation, potential therapeutic inter-
vention, as well as help in improving our understanding of the
DENV life cycle.
Figure 8. Predicted orthologous interactions. (A) Predicted interactions between DENV and orthologous pairs of A.aegypti and human proteins.
The human protein is listed first, followed by its ortholog in A.aegypti which is also predicted to interact with the DENV protein. (B) GO biological
process terms enriched among the interactions predicted to be conserved between human and A.aegypti. ‘‘reg synaptic growth at junction’’ is an
abbreviation for ‘‘regulation of synaptic growth at neuromuscular junction,’’ and ‘‘cell morph in differentiation’’ stands for ‘‘cell morphogenesis
involved in differentiation.’’
doi:10.1371/journal.pntd.0000954.g008
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Figure S1 GO term enrichment of A. aegypti proteins based on
data from Guo et al. [13]. (A) Enriched GO biological process
terms. (B) Enriched GO molecular function terms. Light blue bars
represent terms for A. aegypti targets, and pink is for terms from
DENV-similar proteins. When more than ten terms were enriched
for a set of proteins, only the ten most signicant terms are shown.
Bonferroni corrected p-values were transformed by -log10. The
following abbreviations are used: "translation factor nucleic acid
bind" is "translation factor activity nucleic acid binding," and
"macromolecular subunit organiz" is "macromolecular complex
subunit organization."
Found at: doi:10.1371/journal.pntd.0000954.s001 (1.39 MB TIF)
Figure S2 Interactions predicted using both the original fly data
and the mosquito interactome.
Found at: doi:10.1371/journal.pntd.0000954.s002 (0.51 MB TIF)
Table S1 Predicted interactions between DENV2 and human.
Columns include the the DENV protein’s Entrez Protein accession
or PDB code, Uniprot accession, and name; the DENV-similar
protein’s PDB code, Uniprot accession, Entrez Gene ID, and
Symbol; the target protein’s Uniprot accession, Entrez Gene ID,
and Symbol; if the target is a known host factor; and if the
predicted interaction was already known in the literature.
Found at: doi:10.1371/journal.pntd.0000954.s003 (4.18 MB
TXT)
Table S2 Predicted interactions between DENV2 and A. aegypti.
Columns include the the DENV protein’s Entrez Protein accession
or PDB code, Uniprot accession, and name; the DENV-similar
protein’s PDB code, Uniprot accession, Entrez Gene ID, and
Symbol; the D. melanogaster target protein’s FlyBase gene number,
and Symbol; the A. aegypti target protein’s VectorBase protein ID,
and Uniprot accession; and if the target is a known host factor.
Found at: doi:10.1371/journal.pntd.0000954.s004 (4.18 MB
TXT)
Table S3 Predicted interactions between DENV2 and human
after the CC Filter. Columns include the the DENV protein’s
Entrez Protein accession or PDB code, Uniprot accession, and
name; the DENV-similar protein’s PDB code, Uniprot accession,
Entrez Gene ID, and Symbol; the target protein’s Uniprot
accession, Entrez Gene ID, and Symbol; if the target is a known
host factor; and if the predicted interaction was already known in
the literature.
Found at: doi:10.1371/journal.pntd.0000954.s005 (3.01 MB
TXT)
Table S4 Predicted interactions between DENV2 and A. aegypti
after the CC Filter. Columns include the the DENV protein’s
Entrez Protein accession or PDB code, Uniprot accession, and
name; the DENV-similar protein’s PDB code, Uniprot accession,
Entrez Gene ID, and Symbol; the D. melanogaster target protein’s
FlyBase gene number, and Symbol; the A. aegypti target protein’s
VectorBase protein ID, and Uniprot accession; and if the target is
a known host factor.
Found at: doi:10.1371/journal.pntd.0000954.s006 (0.01 MB
TXT)
Table S5 Predictions involving orthologous human and A. aegypti
target proteins. Columns include the the DENV protein’s Entrez
Protein accession or PDB code, and name; the A. aegypti target
protein’s VectorBase protein ID, Uniprot accession, and if it is a
known host factor; the human target protein’s Uniprot accession,
Symbol, if it is a known host factor, and if the human interaction
was already known in the literature.
Found at: doi:10.1371/journal.pntd.0000954.s007 (0.01 MB
TXT)
Table S6 Predicted interactions between DENV2 and A. aegypti.
Columns include the the DENV proteins Entrez Protein accession
or PDB code, Uniprot accession, and name; the DENV-similar
proteins PDB code, Uniprot accession, species, gene ID, and
description; the A. aegypti ortholog proteins VectorBase pro- tein
ID, geneID, and Uniprot; the A. aegypti target proteins VectorBase
protein ID, gene ID, Uniprot accession, and description; and if the
target is a known host factor or was also predicted by another
group [13].
Found at: doi:10.1371/journal.pntd.0000954.s008 (0.04 MB
TXT)
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